Navigation Links
Independent Laboratory Testing Shows BioNeutral's Hospital Grade Ygiene(TM) Eliminates Aspergillus Niger (Black Mold) Spores
Date:7/7/2009

NEWARK, N.J., July 7 /PRNewswire-FirstCall/ -- BioNeutral Group, Inc. ("BioNeutral") (OTC Bulletin Board: BONU), a chemical technology-based Life Science company announced today that independent laboratory testing performed by ATS Labs shows that Aspergillus Niger mold spores are completely eliminated by the Company's Ygiene(TM) Hospital Grade antimicrobial in record time.

ATS Labs, using the EPA required Fungicidal Use Dilution test, showed that approximately 2.5 million Aspergillus Niger spores were totally eliminated within two (2) minutes. Aspergillus Niger is a type of black mold spore which is a prolific human heath threatening problem. The spore form of this black mold is particularly difficult to eliminate and total eradication is required in order to alleviate associated health threatening issues.

BioNeutral's Chief Science Officer, Dr. Andy Kielbania, PhD. stated, "These results are particularly important because they both validate our internal lab testing protocols and also confirm the speed, efficacy and power of our Ygiene(TM) antimicrobials. The sporicidal efficacy against Aspergillus Niger (Black Mold) is a key accomplishment for our company." He continued, "These independent lab test results represent a significant achievement. Based upon these results we believe our hospital grade Ygiene(TM) will easily eliminate any health threatening bacteria including very dangerous and difficult to kill antibiotic resistant forms including, Methicillan Resistant Staphylococcus Aureus often referred to as "MRSA", drug resistant Pseudomonas Aeruginosa and the very difficult to eradicate pan resistant Klebsiella Pneumoniae. Obviously the new strain of H1N1 virus (Swine Flu) will not present any problem for our formula to achieve a total Kill in record time."

In an article in Environmental Business International, Inc., The Chelsea Group, an Indoor Air Quality (IAQ) consulting and market research fir
'/>"/>

SOURCE BioNeutral Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Independent Health to Begin Offering Its Members Vitamins, Supplements and Natural Products
2. New Technology Assists Independent Seniors
3. Helping Dad Stay Independent: The Best Fathers Day Gift for an Aging Parent - A Checklist from Dr. Dan Tobin, Founder and CEO of Care Support of America
4. Three Independent Proxy Advisory Firms Support Stockholder Nominees in Amylin Proxy Fight
5. Support Bristols Highly Qualified Independent Nominees for Advocat Board
6. Gentiva(R) Health Services Receives Nasdaq Notification Regarding Independent Director Requirement
7. Important Data Presented on Independent Predictors of Mortality in Patients With Idiopathic Pulmonary Fibrosis
8. New Organization Formed To Save Independent Medical Equipment Suppliers
9. Super Lice Repelled by All-Natural Products First Ever Independent Study Shows
10. Quigley Corporation Receives Support from Leading Independent Proxy Advisory Firms; RiskMetrics and Glass Lewis Reject Dissident Stockholder Ted Karkus, Citing Failure to Provide Detailed Business Plan
11. Vigilan Honors National Nurse Week in Assisted Living, Independent Living and Dementia Care
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo 2Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo 3Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo 4Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 2Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 3Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 4Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 5Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 6Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 7Hobby Lobby Selects Concentra to Open Health Center 62350 1Hobby Lobby Selects Concentra to Open Health Center 62350 2Hobby Lobby Selects Concentra to Open Health Center 62350 3Northwestern Mutual Survey Reveals That Most Americans Are Putting Their Income at Risk 62348 1Northwestern Mutual Survey Reveals That Most Americans Are Putting Their Income at Risk 62348 2Northwestern Mutual Survey Reveals That Most Americans Are Putting Their Income at Risk 62348 3Nations Oldest AIDS Organization Launches Innovative Tool to Reach New Faces of HIV on World AIDS Day 62346 1Nations Oldest AIDS Organization Launches Innovative Tool to Reach New Faces of HIV on World AIDS Day 62346 2Nations Oldest AIDS Organization Launches Innovative Tool to Reach New Faces of HIV on World AIDS Day 62346 3